Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

418 results

Complex and challenging cases I

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to manage complex complications, with a selection of challenging clinical cases such as: high-risk left main artery, stent ablation and rota-stenting, LT main lesion, and more!

Complex and challenging cases I

Interactive Case Corner 4 - Wandering stent

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover the case of a high-risk patient accepted for LM and multivessel PCI, and learn more about the transulnar approach strategy and benefits.

Interactive Case Corner 4 - Wandering stent

An NSTEMI case due to a severe LM calcific sub-occlusive stenosis

22 Oct 2019

View this case of an 85-year-old woman, hypertensive under medical therapy with no previous medical or surgical history, who called the emergency services about chest pain and shortness of breath...

Author

Flavio Luciano Ribichini
NSTEMI case due to a severe LM calcific sub-occlusive stenosis

Three-year outcomes of the DKCRUSH-V trial comparing DK crush with provisional stenting for left main bifurcation lesions

15 Oct 2019

DKCRUSH-V showed lower rates of target lesion failure at one year in the DKCRUSH arm, mainly driven by increased rates of target vessel MI. In this paper, the authors report the extended follow-up to three years.

Nicola Ryan

Reviewer

Nicola Ryan
Dejan Milasinovic

Reviewer

Dejan Milasinovic
Three-year outcomes of the DKCRUSH-V trial comparing DK crush with provisional stenting for left main bifurcation lesions

Editor's picks: impactful articles in interventional cardiology

01 Oct 2019

Struggling to keep up with the mass of scientific information in interventional cardiology? On this page you will find a selection of recent articles published in major journals in the field - use it to guide your reading!

What's hot in interventional cardiology?

EXCEL: 5-year outcomes from a randomized trial of PCI vs. CABG in patients with left main coronary artery disease

01 Oct 2019

At TCT 2019 in San Francisco - USA, Gregg W. Stone presented the results of the EXCEL trial. Read the summary and analysis provided by Luis Ortega-Paz.

Luis Ortega-Paz

Author

Luis Ortega-Paz
EXCEL: 5-year outcomes from a randomized trial of PCI vs. CABG in patients with left main coronary artery disease

IDEAL-LM: A randomized trial of a bioabsorbable polymer DES with 4-month DAPT vs. a durable polymer DES with 12-month DAPT in patients with left main coronary artery disease

27 Sep 2019

At TCT 2019 in San Francisco - USA, Robert-Jan Van Geuns presented the results of the IDEAL-LM trial. Read the analysis by Christopher Cook.

Author

Christopher Cook
IDEAL-LM: A randomized trial of a bioabsorbable polymer DES with 4-month DAPT vs. a durable polymer DES with 12-month DAPT in patients with left main coronary artery disease

PCR @ TCT 2019

17 Sep 2019

View reviews of a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2019 Transcatheter Cardiovascular Therapeutics Scientific Sessions. Check out the list here!

PCR @ TCT 2019

SYNTAXES - Ten-year survival after coronary artery bypass grafting vs PCI: the SYNTAX Extended Survival study

03 Sep 2019

At the ESC Congress 2019 in Paris, Daniel Johannes presented the results of the SYNTAX Extended Survival study. Read the report by Mirvat Alasnag.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
SYNTAXES - Ten-year survival after CABG versus PCI: the SYNTAX Extended Survival study

New innovative solutions for serious needs: check it out!

28 Aug 2019 – From EuroPCR 2019

Consult this session to discover new innovative solutions for serious needs, such as the Ultraseal device, the V-LAP system, and more!

New innovative solutions for serious needs